Qué ha sido de la leishmaniasis?

Anales Espanoles de Pediatria

Volumn 49, Issue 1, 1998, Pages 5-10

  Moral Gil, L ^a   Moya Benavent, M ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; HUMAN; PRESCHOOL CHILD; REVIEW; SPAIN; VISCERAL LEISHMANIASIS; ANOPHELES; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA TROPICA; LEISHMANIASIS; PHLEBOTOMUS;

CHILD; CHILD, PRESCHOOL; HUMANS; LEISHMANIASIS, VISCERAL; SPAIN;

EID: 0032112893     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. WHO expert committee. Control of the leishmaniases. Geneva: World Health Organization; 1990.
2. Alvar J. Leishmaniasis. En: Tratado de Medicina Interna. Medicine. 4aed. Barcelona: Idepsa, 1986: 3025-3032.
3. Cruz M, Ferrando J, Corretger JM. Dermatologia pediatrica. En: Cruz M, ed. Tratado de Pediatria. T ed. Barcelona: Espaxs, 1993:2090-2106.
4. Aguilera L, Ferez M, Garci'a MJ. Leishmaniasis. Paludismo. En: Zafra MA, Calvo C, García ML, Baquero F, Arribas N, Jiménez J, Bueno M, eds. Manual de diagnostico y terapéutica en pediatria. 3a éd. Madrid: Publires, 1996: 374-379.
5. Izento C, Gonzalez-Ensenat MA. Cas 97.2. Pediatr Catalana 1997; 57:188-189.
6. Comín J, Herrero P, Sancho V. El problema del kala-azar infantil en el Levante espanol. Act Fed Esp 1947; 5:379-407.
7. Botet J, Portus M. La leishmaniosis en la Espaiia peninsular. Revision histôrico-bibliogrdfica (1912-1985). Rev San Hig Pub 1993; 67:255-266.
8. Gômez J, Medrano C, Navarro M, et al. Kala-azar en la infancia: a propôsito de 34 casos y révision de la literatura. Rev Esp Pediatr 1994;50:339-343.
9. Amat A, Ros J, Roca J, Pou J. Leishmaniasis viscéral. A propösito de 31 casos. Revision de 14 aiïos. Arch Pediatr 1995; 46:254-259.
10. Lopez LF, Clémente F, de la Cruz E, et al. Kala-azar infantil: casufstica de una década. An Esp Pediatr 1993; 39:199-201.
11. Gradoni L, Bryceson A, Desjeux P. Treatment of Mediterranean visceral leishmaniasis. Bull WHO 1995; 73:191-197.
12. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.
13. Gil J. Phlébotomes et leishmanioses en Espagne. En: Ecologie des Ieishmanioses. Colloques Int CMRS (Montpellier) 1977; 239:177-190.
14. Anönimo. Leishmaniasis epidemic in Southern Sudan. Wkly EpidemiolRec 1993; 68:41-42.
15. Ferrer LI. Leishmaniosis canina en Espana: datos para el clînico. Enf Infec Microbiol Clin 1989; 7:293-295.
16. Portus M. Leishmaniosis canina. Enf Infec Microbiol Clin 1990; 8:251.
17. Alvar J, Amela C, Molina R. El perro como reservorio de la leishmaniosis. Med Vet 1995; 12.
18. Tesh RB. Control of zoonotic visceral leishmaniasis: Is it time to change strategies? Am J Trop Med Hyg 1995; 52:287-292.
19. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996; 55:125-130.
20. Quiles J. La leishmaniosis visceral infantil durante la década 1943-1952 en la Vega Baja del Rio Segura. Arch Pediatr 1953; 3:497-506.
21. Quiles J. Leishmaniosis infantil. Bol Soc Val Ped 1962; 4:437-442.
22. Orts P. Leishmaniosis infantil. Comentarios a nuestra casuîstica en una comarca de la provincia de Alicante. Bol Soc Val Ped 1964; 6:235-242.
23. Pampiglione S, Manson-Bahr PEC, La Plaça M, et al. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg 1975; 69:60-68.
24. Pampiglione S, Manson-Bahr PEC, La Plaça M, et al. Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Irans R Soc Trop Med Hyg 1976; 70:62-65.
25. Gramiccia M, Bettini S, Gradoni L, et al. Leishmaniasis in Sardinia. 5. Leishmanin reaction in the human population of a focus of low endemicity of canine leishmaniasis. Irans R Soc Trop Med Hyg 1990; 84:371-374.
26. el Hassan AM, Zijlstra EE, Ismael A, Ghalib HW. Récent observations on the epidemiology of kala-azar in the eastern and central states of the Sudan. Trop CeogrMed 1995; 47:151-156.
27. Pampiglione S, Manson-Bahr PEC, Giungi F, et al. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1974; 68:447-453.
28. Badarö R, Jones TC, Lorenço R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986; 154:639-649.
29. Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154:1003-1011.
30. Bettini S, Pampiglione S, Maroli M. Studies on Mediterranean leishmaniasis. V. A preliminary epidemiological survey of human leishmaniasis in Tuscany. Trans R Soc Trop Med Hyg 1977; 71:73-79.
31. Bettini S, Gramiccia M, Gradoni L, et al. Leishmaniasis in Tuscany (Italy): VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitai Hum Comp 1983; 58:539-547.
32. Gradoni L, Pizzuti R, di Martino L, et al. The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing. Epidemiol Infect 1993; 111:297-306.
33. Marty P, Le Fichoux Y, Giordana D, Brugnetti A. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans R Soc Trop Med Hyg 1992; 86:249-250.
34. Marty P, Lelievre A, Quaranta J-F, et al. Use of the leishmanin skin test and Western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in AlpesMaritimes (France). Trans R Soc Trop Med Hyg 1994; 88:658-659.
35. Acedo C, Martin J, Vêlez ID, et al. Leishmaniasis eco-epidemiology in the Alpujarra region (Granada province, southern Spain). Int J Parasitol 1996; 26:303-310.
36. Morillas F, Sânchez Rabasco F, Ocafia J, et al. Leishmaniosis in the focus of the Axarquîa region, Malaga province, southern Spain: a survey of the human, dog, and vector. Parasitai Res 1996; 82:569-570.
37. Alvar J, Gutiérrez-Solar B, Pachön I, et al. AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clin Dermatol 1996; 14:541-546.
38. Tabernero M, Barrio MI, Garcia MJ, Zapico R. ^Existen leishmaniasis asintomâticas en Espaiïa? An Esp Pediatr 1990; 33:96-97.
39. Gutiérrez J, Maroto MC, Piédrola G, Higuera A. Prevalencia de anticuerpos anti-Leishmania en individuos adictos a drogas por via parenteral. Rentabilidad de dos técnicas de estudio. Med Clin (Bare) 1993;100:168-170.
40. Anönimo. Vigilancia epidemiolögica de la leishmaniasis. Butll Epidemiol 1988; no. 77 y no. 78.
41. Generalität Valenciana. Conselleria de Sanitat i Consum. Gabinete Técnico de la Secretaria General. Libro Blanco de la Salud en la Comunidad Valenciana. Generalität Valenciana, Valencia; 1991. pp 515 y 531.
42. Wilson ME. Leishmaniasis. Curr Opin Infect Dis 1993; 6:331-341.
43. Baily GG, Nandy A. Viscéral leishmaniasis: more prevalent and more problematic. J Infect 1994; 29:241-247.
44. Gradoni L, Gramiccia M. Leishmania infantiim tropism: Strain genotype or host immune status? Parasitai Today 1994; 10:264-267.
45. Pearson RD, De Queiroz Sousa A. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996; 22:1-13.
46. Bacellar O, Brodskyn C, Guerreiro J, et al. Interleukin-12 restores interferon-y production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 1996; 173:1515-1518.
47. Pearson RD, Cox G, Jeronimo SMB, et al. Visceral leishmaniasis: a model for infection-induced cachexia. Am J Trap Med Hyg 1992; 47 Suppl:8-15.
48. Locksley RM, Louis JA. Immunology of leishmaniasis. Curr Opin Iimmmol 1992; 4:413-418.
49. Tanner C. Immunobiology of visceral leishmaniasis. Clin Immunol Iminunopathol 1996; 78:105-111.
50. Kemp M. Regulator and effector functions of T-cell subsets in human Leishmania infections. APMIS 1997; 105 (Suppl. 68):l-33.
51. Azulay RD, Azulay DR. Immune-clinical-pathologic spectrum of leishmaniasis. IntJDennatol 1995; 34:303-307.
52. Magill AJ, Grögl M, Gasser RA, et al. Visceral infection caused by Leishmania tropica in veterans of operation desert storm. N Engt J Med 1993; 328:1383-1387.
53. Sacks DL, Kenney RT, Kreutzer RD, et al. Indian kala-azar caused by Leishmania tropica. Lancet 1995; 345:959-961.
54. Alvar J, Ballesteros A, Soler R, et al. Mucocutaneous leishmaniasis due to Leishmania (Leishmania) infantum: Biochemical characterization. Am J Trop Med Hyg 1990; 43:614-618.
55. Cabello PH, Dias Lima AMVM, Azevedo ES, Krieger H. Familial aggregation of Leishmania chagasi infection in northeast Brazil. Am J Trop Med Hyg 1995; 52:364-365.
56. Blackwell JM. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996; 112 Suppl:S67-S74.
57. Hanison LH, Naidu TG, Drew JS, et al. Reciprocal relationships between undemutrition and the parasitic disease visceral leishmaniasis. Rev Infect Dis 1986; 8:447-453.
58. Cerf BJ, Jones TC, Badaro R, et al. Malnutrition as a risk factor for severe visceral leishmaniasis. JInfectDis 1987; 156:1030-1033.
59. Dye C, Williams BG. Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited. Proc R Soc Land B Biol Sei 1993;254:33-39.
60. Bhattacharyya J, Bhattacaryya A, Hati AK. Visceral leishmaniasis: an anthropométrie study. Ann Trop Med Parasitai 1995; 89:83-84.
61. De Rossell RA, De Durân RJ, Rossell 0, Rodriguez AM. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg 1992; 86:251-253.
62. Montalbdn C, Calleja JL, Erice A, et al. Viscéral leishmaniasis in patients infected with human immunodeficiency virus. J Infect 1990; 21:261-270.
63. Golino A, Duncan M, Zeluff B, et al. Leishmaniasis in a heart transplant patient. J Heart Lung Transplant 1992; 11:820-823.
64. Wright MI. Kala-azar of unusual duration, associated with agammaglobulinaemia. BMJ 1959; 1:1218-1221.
65. Symmers WSC. Leishmaniasis acquired by contagion. A case of marital infection in Britain. Lancet 1960: ii:127-132.
66. Bada JL, Arderiu A, Giménez J, Gömez-Acha JA. Kala-azar of longstanding evolution in an asplenic patient. Trans R Soc Trop Med Hyg 1979; 73:347-348.
67. Jewell AP, Giles FJ. Cutaneous manifestation of leishmaniasis 40 years after exposure in a patient with chronic lymphocytic leukaemia. Leuk Lymphoma 1996; 21:347-349.
68. Dedet JP, Lambert M, Pratlong F. Leishmanioses et infection par le virus de l'immunodéficience humaine. Presse Med 1995; 24:1036-1040.
69. Alvar J, Canavate C, Gutiérrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10:298-319.
70. Alvar J. Leishmaniasis and AIDS co-infection: The Spanish example. Parasitai Today 1994; 10:160-163.
71. De Gôrgolas M, Miles MA. Visceral leishmaniasis and AIDS. Nature 1994; 372:734.
72. Dereure J, Reynes J, Pratlong, et al. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull WHO 1995; 73:245-246.
73. Mikou N, Balafrej A, Benhamou B, et al. Leishmaniose viscérale infan-tile au Maroc. Ann Pediair (Paris) 1991; 38:497-502.
74. Lagardere B, Chevallier B, Cheriet R. Le kala azar. Ann Pediatr (Paris) 1992; 39:159-164.
75. Pousse H, Besbes A, Ben Said M, et al. Epidemiology of human visceral leishmaniasis in Tunisia. J Trop Pediatr 1995; 41:191-192.
76. Harrat Z, Pratlong F, Belazzoug S, et al. Leishmania infanliim and L major in Algeria. Trans R Soc Trop Med Hyg 1996; 90:625-629.
77. Belhadj S, Djaiet-Baraket Z, Jemli B, et al. Leishmanioses viscé rales et cutanées du nord. Etude rétroactive des cas diagnostiques a l'hôpital La Rabta de Tunis. Bull Soc Palhol Exot 1996; 89:269-273.
78. Amela C, Lôpez Gay D, Alberdi JC, Castilla J. Injecting drug use as a risk factor for visceral leishmaniasis in AIDS patients. Eur J Epldemiol 1996; 12:91-92.
79. Perrin C, Taillan B, Del Guidice P, et al. Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern. Clin Infect Dis 1997; 24:1283.
80. Molina R, Canavate C, Cercenado E, et al. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus pemidosus. AIDS 1994; 8:277-279.
81. Pineda JA, Macîas J. Kala-azar en la infeccion por VIH, £la punta del iceberg? Med Clin (Bare) 1996; 106:697-699.
82. de Juan F, Gomez V, Garcia C, et al. Leishmaniosis visceral reveladora de infeccion por VIH postransfusional. An Esp Pediatr 1991; 34:158-160.
83. Guarino A, Gaeta GB, Gradoni L. Visceral leishmaniasis in a child with HIV-1 infection. EurJ Pediair 1994; 153:301-302.
84. Hill FGH, Letsky EA. Infantile kala-azar in Britain. BMJ 1975; 9:354-355.
85. Koht AS, Thompson MH. Visceral leishmaniasis contracted in the Mediterranean area. Arch Dis Child 1983; 58:930-931.
86. Kinmond S, Galea P, Simpson EM, et al. Kala-azar in a Scottish child. Lancet 1989; 11:325.
87. Jeannel D, Tuppin P, Brucker G, et al. Imported and autochthonous kala-azar in France. BMJ 1991; 303:336-338.
88. Granert C, Blinder G, Ost A, Henter J-I. Kala-azar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis. Ada Pdiatr 1993; 82:794-796.
89. Emeis M, Liesenfeld 0, Henze G, et al. Importierte viszerale Leishmaniose (Kala Azar) bei einem deutschen Kleinkind. Klin Padiatr 1995; 207:347-349.